It uses electromagnetic waves to target tumors and is available to patients for whom first- and second-line treatments have ...

Randomized Phase 2 study initiated evaluating the combination of casdozokitug, toripalimab and bevacizumab in patients with liver cancer ...

Ensartinib has received FDA approval for the first-line treatment of ALK-positive locally advanced or metastatic non–small ...

From detecting early disease to guiding treatment plans, clinicians are finding ctDNA testing increasingly important.

Ensartinib has received FDA approval for the first-line treatment of anaplastic lymphoma kinase (ALK)-positive locally ...

For many people with early breast cancer (eBC), remission doesn’t mean everything goes back to normal. There are scars from ...

Stock analysts at Cantor Fitzgerald began coverage on shares of TriSalus Life Sciences (NASDAQ:TLSI – Get Free Report) in a research note issued on Tuesday, Marketbeat.com reports. The brokerage set ...

a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of primary and ...

Dr Mayowa Kolade, a consultant nuclear medicine specialist at the University College Hospital, Ibadan, in this interview with ...

"According to the World Health Organization, about one third of cancers can be prevented through measures like proper ...

Liam Handley - who had suffered from anxiety for much of his life - went to his GP with chest pains, which his doctor put ...

Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology, today announced five presentations featuring botensilimab (BOT, an Fc-enhanced anti-CTLA-4 antibody) plus balstilimab (BAL, an anti-PD-1 ...